Figure 5.
Design strategy resulting in multi-target ligand M30D, which contains propargylamine moiety (blue part) from anti-PD drug rasagiline and (dimethylcarbamoyl)oxy moiety (red part) from anti-AD drug rivastigmine.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.